Mylan Defends EpiPen Price Hike

Why do smart people often do dumb things? Would you plagiarize a speech that you know is going to be carefully scrutinized? Would you respond to a robocall that congratulates you on winning a free cruise? Would you keep eating sushi that didn’t smell right?

I’m certainly not judging anyone here. I’ve had plenty of my own misadventures and I periodically add to the list.

Our presidential candidates fall prey to human error and misjudgments surprisingly often. Aren’t these folks supposed to be pros or at least managed by honed handlers? Why would Donald Trump have insulted nearly every constituency and rival during the primary election process knowing that this might render him unelectable in the general election? Why would Hillary Clinton demand unconscionable speaking fees from special interest groups when she knew that she would pursue the presidency and her payoffs would be publicized?

I’ll leave it to readers to ponder their own responses to the above inquiries.

If the sushi doesn't pass the sniff test, head to Burger King.

Last year, I posted on a drug company that raised the price of a pill from $13.50 to $750.00. Even if such a practice is legal, or is justified by market forces, it is very, very dumb. It is guaranteed to provoke outrage and will surely result in scrutiny that will go much wider and deeper than the initial offense. It did. For more details, just click here.

One would think that rival pharmaceutical companies would be more cautious before enacting similar price gouging. Guess again. Mylan, who makes EpiPen, raised the price of this product about 500% over the past years, bringing the price to $608 for a two pack. The company stands by the new pricing. Sure, they have offered a few discount coupons, but they are leading from way behind. They are not likely to prevail, even if they have a potent economic argument.

This stuff is ripe grist for politicians, who can rail against the pharmaceutical barons, in order to distract the public from their own abysmal performance. And, angry parents will use social media and other methods to publicize their outrage. The fact that many patients who rely upon EpiPens are young children doesn’t make the company’s case any easier.

If Mylan’s CEO Heather Bresch is called to testify, how will the optics be when she states that her compensation last year was about $19 million?

Why are so many pharmaceutical folks so allergic to good judgment? Perhaps, they should carry around an EpiPen, if they can afford it.

Comments

Becoming a Part-Time Physician

Next month my schedule will change. I will henceforth be off on Fridays with my work week truncated to Monday through Thursday. I am excited to be enjoying a long weekend every weekend. And while the schedule change is relatively minor, this event does feel like an important career moment for me. It is the first step on a journey that will ultimately lead beyond my professional career. It is this recognition that makes this modest schedule modification more significant than one would think it deserves. As some readers know, my current employed position has been a dream job for me. Prior to this, I was in a small private practice, which I loved, but was much more challenging professionally and personally. My partner and I ran the business. Working nights, weekends and holidays were routine for decades. On an on-call night, if I slept through until morning, I felt as if I had won the lottery. And w...

When Should Doctors Retire?

I am asked with some regularity whether I am aiming to retire in the near term. Years ago, I never received such inquiries. Why now? Might it be because my coiffure and goatee – although finely-manicured – has long entered the gray area? Could it be because many other even younger physicians have given up their stethoscopes for lives of leisure? (Hopefully, my inquiring patients are not suspecting me of professional performance lapses!) Interestingly, a nurse in my office recently approached me and asked me sotto voce that she heard I was retiring. “Interesting,” I remarked. Since I was unaware of this retirement news, I asked her when would be my last day at work. I have no idea where this erroneous rumor originated from. I requested that my nurse-friend contact her flawed intel source and set him or her straight. Retirement might seem tempting to me as I have so many other interests. Indeed, reading and ...

Will Smarter Lawyers End Frivolous Lawsuits?

How do you know if a lawyer is any good? Of course, they've all passed the bar, but now their profession is lowering it. While most of us strive for excellence, and raise our children to value this virtue, prominent legal educators are establishing a new quality intitiative for their profession. Who says that lawyers can't reform themselves? Perhaps, we physicians can follow their bold example and raise the credentials of our pre-medical students. I’ll present the facts. You be the judge. I have written a dozen posts on tort reform on this blog, which always generate spirited and adversarial retorts from attorneys and their supporters. They accuse me and other tort reform advocates of carrying water for insurance companies. They repeatedly point out that I know nothing about the legal system and are unqualified to opine on its flaws. They deride me when I argue that effective tort reform would reduce the practice of defensive medicine, despite the re...

MD Whistleblower

Search This Blog